TissueGen to Feature ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M West

17 Jan TissueGen to Feature ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M West

WHO: TissueGen® Inc., developer of patented ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

WHAT: TissueGen will be exhibiting ELUTE fiber in booth 1485 at MD&M West. ELUTE fiber advances the state-of-the-art for controlled sustained delivery of biologics and pharmaceuticals from topical and implantable medical devices. ELUTE fiber manufacturing overcomes the challenges of heat and shear stress traditionally associated with melt extrusion and provides the potential benefit of stability and structural support not possible from other drug delivery formats such as microspheres and nanoparticles. TissueGen’s patented manufacturing process occurs at room temperature, enabling the widest range of sensitive biologics and pharmaceuticals ever possible to be delivered from biodegradable implantable devices.

To learn how ELUTE fiber enables the next generation of medical device breakthroughs across a broad range of medical applications, please contact Christopher Knowles at cknowles@tissuegen.com or 1.214.351.1922 to set up a meeting.

WHERE:
MD&M West
Booth 1485
Anaheim Convention Center
Anaheim, CA

WHEN: MD&M West will take place from February 6-8, 2018.

To schedule a briefing, please contact Sage Morander at sage.morander@svmpr.com or 1.401.490.9700.

About TissueGen
TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration and tissue engineering. TissueGen has extensive experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant. By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

For more information contact:

Sage Morander
SVM Public Relations
1.401.490.9700
sage.morander@svmpr.com

No Comments

Sorry, the comment form is closed at this time.